EUVIMEDEUVIMED entdecken
KommentarOpen Access

A roadmap for designing narrow-spectrum antibiotics targeting bacterial pathogens

Xinyun Cao, Robert Landick, Elizabeth A Campbell

microbial Cell · 04.07.2022 · 9 (7) · 136-138

DOI: 10.15698/mic2022.07.780 ↗

Kurz gefasst

Kommentar in der Zeitschrift microbial Cell, online erschienen am 04.07.2022. Verfasst von Xinyun Cao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Wisconsin-Madison; Madison, United States. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clostridioides difficile (Cdiff) infection (CDI) continues to be the leading threat of nosocomial deaths worldwide and a major burden on health-care systems. Broad-spectrum antibiotics eradicate the normal gut microbiome, killing protective commensal bacteria and increasing CDI recurrence. In contrast, Fidaxomicin (Fdx) is a narrow-spectrum antibiotic that inhibits Cdiff growth without affecting crucial gut microbes. However, the basis of the narrow-spectrum activity of Fdx on its target, RNA polymerase (RNAP), in Cdiff has been enigmatic. Recently, Cao et al. (Nature, doi: 10.1038/s41586-022-04545-z) combined transgenic RNAP design and synthesis with cryo-electron microscopy (cryo-EM) to identify a key determinant of Fdx inhibition of Cdiff RNAP. This finding was further corroborated by biochemical, bioinformatics, and genetic analysis. This microreview describes implications of this work for lineage-specific antibiotic design and new directions toward understanding transcription and regulation in Cdiff and other bacterial pathogens.

Schlagwörter

Stichwörter der Autor:innen

Clostridioides difficileRNA polymerasefidaxomicinnarrow-spectrum antibioticstranscription

Autor:innen und Institutionen

  • Department of Biochemistry, University of Wisconsin-Madison; Madison, United States.
  • Department of Bacteriology, University of Wisconsin-Madison; Madison, United States.
  • Laboratory of Molecular Biophysics, The Rockefeller University; New York, United States.

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Cao, X., Landick, R., & Campbell, E. A. (2022). A roadmap for designing narrow-spectrum antibiotics targeting bacterial pathogens. microbial Cell, 9(7), 136-138. https://doi.org/10.15698/mic2022.07.780

Vancouver

Cao X, Landick R, Campbell EA. A roadmap for designing narrow-spectrum antibiotics targeting bacterial pathogens. microbial Cell. 2022;9(7):136-138. doi:10.15698/mic2022.07.780

BibTeX
@article{Cao2022,
  author = {Cao, Xinyun and Landick, Robert and Campbell, Elizabeth A},
  title = {A roadmap for designing narrow-spectrum antibiotics targeting bacterial pathogens},
  journal = {microbial Cell},
  year = {2022},
  volume = {9},
  number = {7},
  pages = {136--138},
  doi = {10.15698/mic2022.07.780}
}
Kostenlos starten →